Article Details
Retrieved on: 2025-07-28 12:48:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... monoclonal antibodies from his portfolio received FDA approval. The transition comes as Aclaris continues to develop its portfolio of immuno ...
Article found on: www.stocktitan.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here